Cidara Therapeutics Inc Sustainability Reports
Cidara Therapeutics, Inc. is a biotechnology company focused on the discovery, development, and commercialization of novel long-acting therapeutics. It leverages its proprietary Cloudbreak platform to develop drug-Fc conjugates targeting viral infections and other serious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300IHQ9Z7RI1X2D22
FIGI: BBG006R5MFV3
4 reports from 2015 to 2024
